MIM
TECH icon

Macroview Investment Management’s Bio-Techne TECH Stock Holding History

Macroview Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$1.02K – 828
2023
Q3 		$1.02K Buy
+15
New +$1.19K ﹤0.01% 661
2021
Q2 		– Sell
-40
Closed -$4K – 444
2021
Q1 		$4K Buy
+40
New +$3.65K 0.01% 274

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Macroview Investment Management's TECH Position: Q4 2023 in Review

Macroview Investment Management sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 15 shares — an estimated $1.02K sold.

Macroview Investment Management first reported a position in TECH in Q1 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

  • Macroview Investment Management reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
  • Macroview Investment Management sold 15 Bio-Techne shares in Q4 2023, an estimated $1.02K.
  • Macroview Investment Management first reported a position in Bio-Techne in Q1 2021 and held it in 2 quarters.
  • Macroview Investment Management's Bio-Techne position peaked at $4K in Q1 2021.
  • 531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.